Drug
B Leo 35299 G
B Leo 35299 G: highest development phase Phase 1, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| B LEO 35299 20 mg/g cream NCT01580488 | Phase 1 | Psoriasis Vulgaris |
Latest
No recent events.
Follow B Leo 35299 G on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.